Articles related to PRECLINICAL RESEARCH

Losartan increased brown-fat metabolic activity in cell and mouse experiments, while a large imaging analysis linked brown fat and ARB exposure with favorable metabolic patterns. Whether the drug can produce similar metabolic effects clinically remains unproven.

Experimental research linked alcohol exposure with microglia-mediated disruption of the brain’s extracellular matrix and subsequent neuronal dysfunction, identifying a neuroimmune mechanism that was also accompanied by extracellular-matrix abnormalities in human tissue samples.

Hypertension was associated with osteoarthritis in a Korean population analysis and accelerated cartilage deterioration through vasopressin signaling in mouse models, identifying a potential disease pathway whose therapeutic relevance in humans remains unproven.

Loss of the membrane-regulating protein NSF in dopamine D2 receptor-expressing neurons was associated with hyperactivity, impulsive behavior, and reduced striatal dopamine signaling in mice. The findings offer mechanistic insight into ADHD biology, although clinical relevance remains unproven.

A multiplexed cytokine and tumor-antigen mRNA immunotherapy produced durable tumor responses in mouse models of pancreatic ductal adenocarcinoma, with approximately half of treated animals remaining disease-free for up to one year, although clinical relevance remains unproven.

Maternal anti-HPA-1a antibodies inhibited β3 integrin activation in laboratory models, with stronger functional inhibition in severe FNAIT cases. The findings suggest a mechanism beyond platelet clearance, but clinical validation remains necessary.